Gland Pharma Receives Tentative Approval for Blood Pressure Meds from USFDA
On 15 November, Gland Pharma announced that it had received tentative approval from the USFDA (US Food and Drug Administration) for its Angiotensin II Injection,...
Tag : Gland Pharma
Gland Pharma July-September Quarterly Report; Net Profit at Rs 194 Crore
Gland Pharma, on 6 November, announced its quarterly earnings for the July-September quarter for the current fiscal year. The company reported a consolidated net profit...
Gland Pharma Shares have Plunged 80% from Record Highs
In an otherwise firm market, shares of Gland Pharma fell 19% to hit a fresh low of Rs 872.10 in intraday trade on Monday. In...
Gland Pharma Shares Fall to 52-Week Low as Q4 Net Profit Falls 72.5%, 29% Revenue Drop
Shares of Gland Pharma plunged nearly 18% in early trade on May 19, hitting their lowest level in 52 weeks, a day after the company...
IDBI Bank, Patanjali Foods Shares Rise After FTSE Listing
Shares of IDBI Bank and Patanjali Foods rose more than 2% on February 20 after being included in the FTSE All World Index. Kotak Mahindra...
Adani Wilmar, Varun Beverages to be Included in Nifty Next 50
As part of the semi-annual review of the National Stock Exchange’s broader market index, Adani Wilmar, Varun Beverages, Canara Bank, Page Industries, and ABB India...
NSE to Include Adani Wilmar, Adani Power in Few Indices from March 31
Leading stock exchange NSE has adjusted the constituents of its main indices, Adani Wilmar and Adani Power. Both companies of Adani Group will be included...
NSE to Replace Stocks in 42 Indices, Remove Paytm from Nifty Next 50
The National Stock Exchange has announced the replacement of 42 stocks in Nifty Next 50, Nifty 500, Nifty 100, Nifty 200, Midcap 150, Midcap 100,...
Gland Pharma Shares Fall on Fears of Undervalued Sale by Chinese Owner
Shares of Gland Pharma continued to fall on October 31, down 23% overall in three sessions, dealers said, amid concerns over a possible stake sale...
Gland Pharma Hits 52-Week Low on Disappointing Second Quarter
Shares of Gland Pharma opened with a fall of 9.5% on October 27 as investors sold shares after a disappointing second quarter of FY23. The...